Roche 1H Dx Revenues Flat, Hit by Currency Exchange | GenomeWeb

NEW YORK (GenomeWeb) — Roche reported today that first half revenues for its Diagnostics division were essentially flat year over year as its molecular diagnostics business sales dropped 2 percent due to the negative effects of currency exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.